SARS-CoV-2 and Cancer: Beyond Immunosuppression

Authors

  • Diogo Mendes Pedro Serviço de Doenças Infeciosas. Centro Hospitalar Universitário de Lisboa Norte. Lisboa. Instituto de Farmacologia e Neurociências. Faculdade de Medicina. Universidade de Lisboa. Lisboa. https://orcid.org/0000-0002-4923-2940
  • Marta Maria Mendes Pedro Unidade de Saúde Familiar LoureSaudável. Agrupamento de Centros de Saúde Loures-Odivelas. Loures. Instituto de Semiótica Clínica. Faculdade de Medicina. Universidade de Lisboa. Lisboa.
  • Emília Valadas Serviço de Doenças Infeciosas. Centro Hospitalar Universitário de Lisboa Norte. Lisboa. Clínica Universitária de Doenças Infeciosas. Faculdade de Medicina. Universidade de Lisboa. Lisboa.
  • Thomas Hanscheid Instituto de Microbiologia. Faculdade de Medicina. Universidade de Lisboa. Lisboa.

DOI:

https://doi.org/10.20344/amp.15640

Keywords:

COVID-19, Immunosuppression, Neoplasms, SARS-CoV-2

Abstract

N/a.

Downloads

Download data is not yet available.

Downloads

Published

2021-03-01

How to Cite

1.
Mendes Pedro D, Mendes Pedro MM, Valadas E, Hanscheid T. SARS-CoV-2 and Cancer: Beyond Immunosuppression. Acta Med Port [Internet]. 2021 Mar. 1 [cited 2024 Nov. 18];34(3):237-. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/15640

Issue

Vol. 34 No. 3 (2021): March

Section

Letters to the Editor

License

All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.

It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.

Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.

After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.

Crossref
Scopus
Google Scholar
Europe PMC